NATHBIOGEN

Nath Bio-Genes (India)

₹238.99
-7.67 (-3.11%)
16 July, 2024 11:12 BSE: 537291 NSE: NATHBIOGEN ISIN: INE448G01010

Start SIP in Nath Bio-Genes (India)

Start SIP

Nath Bio-Genes (India) Performance

Day Range

  • Low 235
  • High 243
₹ 238

52 Week Range

  • Low 167
  • High 264
₹ 238
  • Open Price243
  • Previous Close247
  • Volume45577

Nath Bio-Genes (India) Share Price

  • Over 1 Month + 17.13%
  • Over 3 Month + 27.29%
  • Over 6 Month + 12.39%
  • Over 1 Year + 11.89%

Nath Bio-Genes (India) Key Statistics

P/E Ratio 10.7
PEG Ratio 0.5
Market Cap Cr
Price to Book Ratio 0.7
EPS 19.3
Dividend 0
Relative Strength Index 64.49
Money Flow Index 83.26
MACD Signal 13.75
Average True Range 10.7
Nath Bio-Genes (India) Financials
IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 43322323545
Operating Expenses Qtr Cr 39261719841
Operating Profit Qtr Cr 466374
Depreciation Qtr Cr 11111
Interest Qtr Cr 13232
Tax Qtr Cr 11000
Net Profit Qtr Cr 342332
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 333302
Operating Expenses Annual Cr 282252
Operating Profit Annual in Cr 5049
Depreciation Cr 33
Interest Annual Cr 910
Tax Annual Cr 21
Net Profit Annual Cr 4035
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 7538
Cash from Investing Activity Annual Cr -27-3
Cash from Financing Annual Activity Cr -10-2
Net Cash Flow Annual Cr 3834
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 611573
Fixed Assets Annual Cr 249244
Total Non Current Assets Annual Cr 309272
Total Current Assets Annual Cr 569521
Total Assets Annual Cr 877793
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 321302
ROE Annual % 76
ROCE Annual % 88
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1516
IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 433223235
Operating Expenses Qtr Cr 392617198
Operating Profit Qtr Cr 46637
Depreciation Qtr Cr 1111
Interest Qtr Cr 1323
Tax Qtr Cr 1100
Net Profit Qtr Cr 34233
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 333302
Operating Expenses Annual Cr 283253
Operating Profit Annual in Cr 5049
Depreciation Cr 33
Interest Annual Cr 910
Tax Annual Cr 21
Net Profit Annual Cr 4035
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 7038
Cash from Investing Activity Annual Cr -27-3
Cash from Financing Annual Activity Cr -5-2
Net Cash Flow Annual Cr 3834
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 610573
Fixed Assets Annual Cr 247244
Total Non Current Assets Annual Cr 309272
Total Current Assets Annual Cr 572521
Total Assets Annual Cr 880793
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 321302
ROE Annual % 66
ROCE Annual % 88
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1516

Nath Bio-Genes (India) Technicals

EMA & SMA

Current Price
₹238.99
-7.67 (-3.11%)
pointer
  • Bullish Moving Average
  • ___
  • 11
  • Bearish Moving Average
  • ___
  • 5
  • 20 Day
  • ₹235.39
  • 50 Day
  • ₹217.41
  • 100 Day
  • ₹208.88
  • 200 Day
  • ₹203.68
  • 20 Day
  • ₹232.65
  • 50 Day
  • ₹208.07
  • 100 Day
  • ₹201.72
  • 200 Day
  • ₹203.63

Nath Bio-Genes (India) Resistance and Support

PIVOT
₹248.69
Resistance
First Resistance 252.87
Second Resistance 259.09
Third Resistance 263.27
RSI 64.49
MFI 83.26
MACD Single Line 13.75
MACD 13.89
Support
First Support 242.47
Second Support 238.29
Third Supoort 232.07

Nath Bio-Genes (India) Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 80,381 4,194,281 52.18
Week 151,339 7,739,466 51.14
1 Month 324,219 14,544,473 44.86
6 Month 121,001 6,308,989 52.14

Nath Bio-Genes (India) Result Highlights

Nath Bio-Genes (India) Synopsis

NSE-Agricultural Operations

Nath Bio-Genes is involved in the business activities of Growing of non-perennial crops. Company’s Total Operating Revenue is Rs. 332.62 Cr. and Equity Capital is Rs. 19.00 Cr. for the Year ended 31/03/2024. Nath Bio-Genes (India) Ltd. is a Public Limited Listed company incorporated on 14/07/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L01110MH1993PLC072842 and registration number is 072842.
Market Cap 469
Sales 333
Shares in Float 1.03
No of funds 14
Yield 1.05
Book Value 0.77
U/D Vol ratio 2.8
LTDebt / Equity
Alpha -0.08
Beta 1.42

Nath Bio-Genes (India) Shareholding Pattern

Owner NameMar-24Dec-23Sep-23
Promoters 45.6%45.6%45.6%
Mutual Funds 4.37%4.37%4.37%
Foreign Portfolio Investors 0.27%0.32%0.22%
Financial Institutions/ Banks
Individual Investors 32.25%30.96%30.5%
Others 17.51%18.75%19.31%

Nath Bio-Genes (India) Management

Name Designation
Mr. Satish Kagliwal Managing Director
Mr. Madhukar Deshpande Director
Ms. Ashu Jain Director
Mrs. Jeevanlata Kagliwal Director
Mr. Vadla Nagabhushanam Director
Mrs. Sweta Kagliwal Director
Mr. Hitesh Purohit Director

Nath Bio-Genes (India) Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Nath Bio-Genes (India) Corporate Action

Date Purpose Remarks
2024-05-08 Audited Results & Final Dividend
2024-01-18 Quarterly Results
2023-10-16 Quarterly Results
2023-08-10 Quarterly Results
2023-04-22 Audited Results & Final Dividend

Nath Bio-Genes (India) MF Shareholding

Nath Bio-Genes (India) FAQs

What is Share Price of Nath Bio-Genes (India) ?

Nath Bio-Genes (India) share price is ₹238 As on 16 July, 2024 | 10:58

What is the Market Cap of Nath Bio-Genes (India) ?

The Market Cap of Nath Bio-Genes (India) is ₹454.2 Cr As on 16 July, 2024 | 10:58

What is the P/E ratio of Nath Bio-Genes (India) ?

The P/E ratio of Nath Bio-Genes (India) is 10.7 As on 16 July, 2024 | 10:58

What is the PB ratio of Nath Bio-Genes (India) ?

The PB ratio of Nath Bio-Genes (India) is 0.7 As on 16 July, 2024 | 10:58

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91